Cargando…
Use of Intraarticular Hyaluronic Acid in the Management of Knee Osteoarthritis in Clinical Practice
Autores principales: | Cooper, Cyrus, Rannou, François, Richette, Pascal, Bruyère, Olivier, Al‐Daghri, Nasser, Altman, Roy D., Brandi, Maria Luisa, Collaud Basset, Sabine, Herrero‐Beaumont, Gabriel, Migliore, Alberto, Pavelka, Karel, Uebelhart, Daniel, Reginster, Jean‐Yves |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5432045/ https://www.ncbi.nlm.nih.gov/pubmed/28118523 http://dx.doi.org/10.1002/acr.23204 |
Ejemplares similares
-
Safety of Oral Non-Selective Non-Steroidal Anti-Inflammatory Drugs in Osteoarthritis: What Does the Literature Say?
por: Cooper, Cyrus, et al.
Publicado: (2019) -
Recommendations for the Reporting of Harms in Manuscripts on Clinical Trials Assessing Osteoarthritis Drugs: A Consensus Statement from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)
por: Honvo, Germain, et al.
Publicado: (2019) -
Inappropriate claims from non-equivalent medications in osteoarthritis: a position paper endorsed by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)
por: Bruyère, Olivier, et al.
Publicado: (2017) -
Safety of Intra-articular Hyaluronic Acid Injections in Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis
por: Honvo, Germain, et al.
Publicado: (2019) -
Can We Identify Patients with High Risk of Osteoarthritis Progression Who Will Respond to Treatment? A Focus on Epidemiology and Phenotype of Osteoarthritis
por: Bruyère, Olivier, et al.
Publicado: (2015)